KLKB1 gene editing therapy reduces kallikrein levels in hereditary angioedema
1. In this randomized controlled trial, gene-editing therapy targeting the kallikrein B1 gene (KLKB1) led to a significant reduction in ...
Tag: kallikrein
Sebetralstat improves symptom relief in acute hereditary angioedema attacks
1. An oral dose of sebetralstat increased the time to conventional treatment use and lead to faster symptom relief in ...
#VisualAbstract: Donidalorsen reduces attacks in patients with hereditary angioedema
1. Patients with hereditary angioedema receiving donidalorsen showed reduced rates of angioedema attacks compared to patients receiving placebo treatment. 2. ...